Q9993 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

Short descriptor: Inj., triamcinolone ext rel

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q9993 was terminated as of 2018-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q9993 in the app →

Look up Q9993 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q9993 is the HCPCS Level II code for Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2019-01-01
Termination Date
2018-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q9993 with the canonical source and edition:

Q9993 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q9993

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q9993

Related Codes in Section Q

← Q9992 Buprenorphine xr over 100 mg Q9994 → Enzyme cartridge enteral nut
Q9988 Platelets, pathogen reduced Q9989 Ustekinumab, iv inject,1 mg Q9991 Buprenorph xr 100 mg or less Q9992 Buprenorphine xr over 100 mg Q9994 Enzyme cartridge enteral nut Q9995 Inj., emicizumab-kxwh 0.5 mg Q9996 Ustekinumab- ttwe sub cu inj Q9997 Ustekinumab-ttwe iv inj 1 mg Q9998 Inj ustekinumab-aekn, 1 mg Q9999 Inj ustekinumab-aauz 1 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial